BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Fusion gene-associated TL was first described in chronic myeloid leukemia (CML)2,3, in which a specific TL, i.e. t(9;22), is frequently observed, and BCR-ABL fusion gene transcripts are expressed in leukemia cells.